If the cancer tests negative for over-expression of the her2 / neu oncogene , weekly chemotherapy with taxol or taxotere is an effective option with acceptable side effects .

如果发现癌基因her2/neu表达降低，那么每周一次的化疗和紫杉烷类或泰索帝一起使用疗效显著，副作用也能够接受。

This dramatically reduces the risk of relapse in breast-cancer patients whose tumours make a protein called her2 / neu , and only those women whose tumours produce this protein will respond to the drug .

它能大大降低体内肿瘤可以产生her2/neu蛋白的乳腺癌患者复发的风险，并且，只有那些体内肿瘤可以产生这种蛋白的女性会对该药物做出反应。